I recently subscribed to Centerwatch - an email notification service
about new clincial trials. The following was received today. There is
more info on it, describing in detail what is involved in the study,
criteria for selection at:
http://www.centerwatch.com/studies/stu23624.htm and other ongoing trials
listed on their web site: www.centerwatch.com
Linda Herman
--------- Forwarded message ----------
Date: Sat, 13 Jan 2001 08:10:48 (GMT)
Subject: CW Patient Notification
This email is being sent to notify you that the following new clinical
trial(s) in your selected area of interest have been recently posted
on the CenterWatch web site at http://www.centerwatch.com.
1) Adenosine A2A Blockade with KW-6002 in Parkinson's Disease. This
study is being conducted in:
- Bethesda, MD (http://www.centerwatch.com/studies/stu23624.htm)
This study will evaluate the effects of an experimental drug called
KW-6002 on Parkinson's disease symptoms and on dyskinesias (involuntary
movements) that develop as a result of long-term treatment with levodopa.
This drug blocks the action of the neurotransmitter adenosine, thought to
be involved in producing Parkinson's symptoms.
---------------------------------------------------------
